If AI doesn’t take your job, it’ll change it. A lot.

The new reality will favor those able and willing to collaborate effectively with AI  AI is here. How soon it transforms the economy depends on how fast the technology advances. But experts agree the transition to the “jobs of tomorrow” is already underway. In late 2022, ChatGPT, an AI chatbot developed by San Francisco-based OpenAI, … Continued

The AI Roundtable

Four experts weigh in on the state of generative AI and the impact of ChatGPT. Just to be fair, we also asked the chatbot for its opinions.  Luckbox: On a scale where “1” stands for pocket calculators and “100” is Skynet—the superintelligent group mind that rules the future in the Terminator movies—what’s the current state … Continued

Luckbox Leans in with Mark Cuban

Cost Plus Drugs Company is selling prescription medications at dramatically low prices  What would happen if drug pricing made sense to consumers? Mark Cuban Cost Plus Drug Company, which launched its online pharmacy about a year ago, is trying to answer that question. Its approach is easy to understand—even if it’s difficult to implement. First, … Continued

ADHD Meds? You May Have to Wait

A shortage began with Adderall and spread to Ritalin. A government crackdown made it worse.  As 2023 began, the national Adderall shortage had spread to other drugs used to treat attention-deficit/hyperactivity disorder (ADHD). Experts expect the mess to continue for much of the year.   The shortages started with Adderall—known generically as amphetamine mixed salts—which … Continued

The Luckbox Roundtable

Mark Cuban, the nation’s newest retail drug impresario, joins our expert panel to weigh in on the state of American pharma. Here’s what our panelists say lies ahead. (Luckbox lightly edited the responses for brevity and clarity.)  luckbox: Only 25% of Americans view of the pharmaceutical industry favorably. What’s the biggest problem?  Posner: It’s remarkable … Continued